The intestinal mucosa is covered by a self-renewing layer of epithelium, making it ideal for the study of tissue-specific stem cells and cell fate determination. Lineage-tracing experiments have helped identify genes selectively expressed by intestinal stem cells. One of these marker genes, the Wnt target, leucine-rich-repeat-containing G protein-coupled receptor 5 (Lgr5) is expressed in crypt base columnar cells (CBCs) within the crypt base stem cell niche, which also comprises surrounding Paneth cells and intestinal subepithelial myofibroblasts 1 . In homeostasis, cell fate determination is coupled to position along the crypt-villus (vertical) axis of the epithelium. Stem cell progeny exit the niche, initially as proliferating transit-amplifying cells before progressively differentiating into post-mitotic specialized cells. This is controlled by strict gradients of interacting morphogenssoluble molecules produced by a restricted region of a tissue that form an activity gradient away from source. The phenotypic response of a cell is determined by its position within this concentration gradient 2 . Wnt and bone morphogenetic protein (BMP) pathways form polarized expression gradients along the epithelial vertical axis. Stem cell division and transit-amplifying cell proliferation are driven by high Wnt and low BMP levels in the lower half of the crypt, whereas daughter cell differentiation and apoptosis are controlled by low Wnt and high BMP at the luminal surface 3 . These gradients are maintained partly by diffusion of ligands but also by the restricted paracrine secretion of ligand-sequestering BMP antagonists, such as Gremlin1, Gremlin2 and Noggin, that are exclusively derived from subcrypt myofibroblasts and act locally within the crypt base stem cell niche. These antagonists are thought to prevent BMP activity within the niche, promoting intestinal stem cell function 4 .
The intestinal mucosa is covered by a self-renewing layer of epithelium, making it ideal for the study of tissue-specific stem cells and cell fate determination. Lineage-tracing experiments have helped identify genes selectively expressed by intestinal stem cells. One of these marker genes, the Wnt target, leucine-rich-repeat-containing G protein-coupled receptor 5 (Lgr5) is expressed in crypt base columnar cells (CBCs) within the crypt base stem cell niche, which also comprises surrounding Paneth cells and intestinal subepithelial myofibroblasts 1 . In homeostasis, cell fate determination is coupled to position along the crypt-villus (vertical) axis of the epithelium. Stem cell progeny exit the niche, initially as proliferating transit-amplifying cells before progressively differentiating into post-mitotic specialized cells. This is controlled by strict gradients of interacting morphogenssoluble molecules produced by a restricted region of a tissue that form an activity gradient away from source. The phenotypic response of a cell is determined by its position within this concentration gradient 2 . Wnt and bone morphogenetic protein (BMP) pathways form polarized expression gradients along the epithelial vertical axis. Stem cell division and transit-amplifying cell proliferation are driven by high Wnt and low BMP levels in the lower half of the crypt, whereas daughter cell differentiation and apoptosis are controlled by low Wnt and high BMP at the luminal surface 3 . These gradients are maintained partly by diffusion of ligands but also by the restricted paracrine secretion of ligand-sequestering BMP antagonists, such as Gremlin1, Gremlin2 and Noggin, that are exclusively derived from subcrypt myofibroblasts and act locally within the crypt base stem cell niche. These antagonists are thought to prevent BMP activity within the niche, promoting intestinal stem cell function 4 .
Dysregulation of the homeostatic Wnt-BMP balance can promote intestinal tumorigenesis. The conventional adenoma-carcinoma sequence is commonly initiated by activation of Wnt signaling in the epithelium through adenomatous polyposis coli (APC) or β-catenin (CTNNB1) mutation 5 . However, disrupted BMP signaling can also predispose to intestinal polyps and cancer 6 . Human juvenile polyposis syndrome (JPS) results from inactivating germline bone morphogenetic protein receptor 1a (BMPR1A) or Mothers against decapentaplegic homolog 4 (SMAD4) mutations, and epithelial expression of Nog under the control of villin (Vil1) or fatty-acid-binding protein (Fabp1) regulatory elements causes a JPS-like phenotype in mice 7, 8 . Recently, we demonstrated that human HMPS is caused by a 40-kb duplication upstream of the BMP antagonist GREM1, which results in ectopic epithelial gene expression and resultant BMP signaling antagonism throughout the vertical axis of the intestine 9 ( Supplementary  Fig. 1c-e) . HMPS is an autosomal dominant condition, and untreated individuals develop colorectal cancer at a median age of 47 (ref. 10) . HMPS is named for the distinctive morphology of the polyps, with individual lesions exhibiting mixed adenomatous crypts, epithelial serration and dilated cysts (Fig. 1a) .
Although it has recently been shown that scarce, post-mitotic tuft cells can persist outside the stem cell niche 11 , the majority of differentiated cells (enterocytes, colonocytes and goblet cells) are shed into the lumen within 5 d. As a consequence of this rapid cell turnover, the perpetual stem cell at the crypt base has been considered the cell of origin of colorectal cancer (CRC) 12 . Here, we use a mouse model of HMPS to show that disruption of homeostatic BMP gradients by aberrant epithelial expression of Grem1 alters cell fate determination, allowing cells outside the crypt base stem cell niche to act as tumor progenitors. Furthermore, we demonstrate that this is the pathogenic mechanism underpinning the development of human HMPS polyps and some sporadic intestinal tumors.
RESULTS

HMPS polyps are characterized by ectopic crypt foci formation
All crypts in individuals with HMPS have epithelial GREM1 expression 9 , yet the polyps are discrete, often containing mixed dysplastic and nondysplastic areas. Histopathological review of the polyps revealed ectopic crypt foci (ECFs) that developed orthogonally to the crypt axis and contained actively proliferating cells (Fig. 1a-c and Supplementary Fig. 1b) . Within some polyps, we identified dysplastic cells emerging from ECFs rather than from the crypt base (Fig. 1b) and hypothesized that dysplasia resulted from somatic mutations within the ECFs.
Sanger sequencing of candidate genes in 23 polyps from 14 patients with HMPS revealed a high frequency of CRC driver mutations. We observed mutually exclusive KRAS or BRAF mutations in 100% of lesions and APC, predominantly p.Arg1450X, mutations in 48%. The CpG island methylator phenotype (CIMP) 13 was present in 53% of lesions tested ( Fig. 1d and Supplementary Fig. 2a ). In contrast, we found a very low frequency of known driver mutations in a cohort of JPS polyps with germline BMPR1A mutations (Supplementary Fig. 2b) . Clonal ordering following microdissection of individual HMPS crypts revealed clonal KRAS or BRAF mutations detected throughout entire polyps, including ECFs and the different morphological crypt subtypes (Supplementary Fig. 2d,e) . In contrast, APC mutations were often spatially restricted to dysplastic areas, indicating that Wnt dysregulation was a subsequent event ( Fig. 1e and Supplementary Fig. 2a,c) .
A mouse model of HMPS In order to understand more about the pathogenesis of HMPS, we generated Vil1-Grem1 mice expressing mouse Grem1 cDNA under the control of the intestinal epithelium-specific Vil1 promoter. Epithelial expression of Grem1 was confirmed by in situ hybridization (Fig. 2c) and quantitative RT-PCR (qRT-PCR), with highest levels in the proximal small bowel (Supplementary Fig. 3d ). We assessed BMP signaling using BMP ligand and target gene expression (Supplementary Fig. 3e ) and immunohistochemistry for phosphorylated Smad1, Smad5 and Smad8. There was loss of the normal p-Smad1, p-Smad5 and p-Smad8 staining pattern throughout the vertical axis of the intestines of Vil1-Grem1 mice ( Fig. 2d and Supplementary Fig. 4b ).
Transgenic animals' small intestines were 28% longer than those of their wild-type littermates (n = 10, P < 0.001, t-test), partly owing to an increase in the size and cell count of the villi (P < 0.001, t-test) ( Fig. 2a and Supplementary Fig. 4a) Fig. 2a,d) . Analysis of epithelial cell lineages showed a decrease in the number of goblet cells in both small intestinal (P = 0.01, t-test) and colonic (P = 0.002, t-test) crypts. The presence of lysozyme-positive Paneth cells on the villus (P = 0.038, t-test) of Vil1-Grem1 mice was notable as this is a cell type normally restricted to the small intestinal crypt base (Fig. 2a,d) . In 3-month-old Vil1-Grem1 animals, Grem1-expressing ectopic crypts were seen developing orthogonally to the vertical axis of the widened and flattened small bowel villi (Fig. 2b,c) .
Ectopic crypts budded off to become actively proliferating intravillus lesions, which subsequently developed dysplastic features with concomitant loss of p16 INK4A expression (Fig. 2e) . By 7 months, these lesions had progressed to a pan-intestinal polyposis ( Supplementary  Fig. 4c) , with a median of 183 polyps per mouse. Small intestinal lesions had a mixed serrated, adenomatous and cystic phenotype characteristic of the lesions seen in HMPS (Fig. 2b) .
We observed epithelial Grem1 and membranous β-catenin expression in unaffected intestine and small polyps in the Vil1-Grem1 mice but some larger polyps with more advanced dysplasia exhibited marked downregulation of epithelial Grem1 expression, which correlated with foci of cytoplasmic and nuclear β-catenin staining. Sanger sequencing demonstrated activating Ctnnb1 mutations in some of these lesions ( Fig. 2f and Supplementary Fig. 4d) .
Although the total colonic length was unchanged in Vil1-Grem1 mice, the proximal colonic folds were exaggerated in comparison with wild-type littermates. In Vil1-Grem1 mice hyperplastic-appearing colonic crypts had an increased cell count (P = 0.03, t-test, Fig. 2a) . Crypt crowding meant that ECFs could not be easily distinguished in the colon, but colonic dysplasia originated at the luminal surface and progressed to form lesions that contained all three morphological crypt phenotypes (Fig. 2b) .
These data indicate that aberrant epithelial npg polyps containing the three characteristic morphologies seen in human HMPS lesions. Throughout the bowel, early lesions can be seen developing outside the crypt basal stem cell niche: on the luminal surface in the colon and within ECFs that bud into the villus of the small intestine. Downregulation of epithelial expression in some advanced lesions indicates that epithelial Grem1 is no longer required once epithelial somatic mutation events have occurred.
Vil1-Grem1 mice have enlargement of the progenitor cell pool As the villus ECFs appeared to be the origin of small intestinal dysplasia in the Vil1-Grem1 mice, we looked for increased expression of stem cell markers on the villi of these animals. We crossed Vil1-Grem1 mice with Lgr5-EGFP-IRES-CreER T2 reporter mice 1 but were unable to detect discrete Lgr5-EGFP-positive cells outside of the crypt base stem cell niche, with none seen in the villus ECFs (Fig. 3a) . To confirm this, we mechanically separated crypts and villi from Vil1-Grem1 and age-matched wild-type mice and used qRT-PCR to detect stem cell markers aberrantly expressed in the Vil1-Grem1 mouse villus compartment. Of the stem cell markers tested, Sox9 showed the highest expression in villus cells (Fig. 3b) , and immunostaining for Sox9 confirmed ectopic crypt-specific expression in both human HMPS and Vil1-Grem1 mouse tissue (Figs. 1c and 2d) . Next, we examined the global mRNA expression profiles of Vil1-Grem1 versus wild-type mouse crypt and villus compartments using gene set enrichment analysis (GSEA). GSEA confirmed no significant enrichment of Lgr5-based intestinal stem cell profiles 14, 15 on the villi of Vil1-Grem1 transgenic mice. In contrast, there was enrichment of villus gene programs characterizing proliferating early transit-amplifying cells 15 (normalized enrichment score (NES) 7.35, P < 0.001, Kolmogorov-Smirnov test) with concomitant reduced levels of genes normally expressed in differentiating cells 15 (NES −6.46; P < 0.001). Furthermore, we also observed reduced expression of villus genes regulating apoptosis 16 (NES −2.9; P = 0.008), cellular senescence 17 (NES −2.36; P = 0.026) and autophagy 18 (NES −3.89; P < 0.001) (Fig. 3c) , homeostatic processes that have all been shown to have tumor suppressor roles in early lesions 19, 20 .
A decreasing gradient of ephrin type-B receptor 2 (EphB2) expression from the crypt base along the vertical axis of the intestine has been used to distinguish intestinal stem (EphB2 high ), progenitor (EphB2 medium ) and differentiating (EphB2 low/absent ) cell populations in the mouse and human intestine 15 . Consistent with this and our GSEA findings, EphB2 protein was aberrantly expressed in the ECFs of both Vil1-Grem1 transgenic mouse and human HMPS polyps (Figs. 1c and 2d). Protein expression of cytokeratin 20 (Ck20), a marker of differentiated cells, was reduced or absent in the ECFs of both Vil1-Grem1 mouse and human HMPS polyps (Figs. 1c and 2d) .
Taken together, these data indicate that epithelial Grem1 expression disrupts the coupling of cell fate to position along the vertical axis of the intestine. Although cell fate-position uncoupling does not generate an ectopic Lgr5-positive stem cell population, it does cause expansion of an Lgr5-negative proliferating progenitor cell population on to the villi. Concomitant downregulation of differentiation, apoptosis, senescence and autophagy gene programs means there is a marked expansion of a progenitor cell pool outside of the intestinal stem cell niche that can be defined immunohistochemically as Sox9 + EphB2 + Ck20 − (Figs. 1c and 2d) .
Epithelial Grem1 promotes persistence of somatically mutant villus cells In order to test the clonogenic, tumor-forming potential of villus cells in our Vil1-Grem1 mouse model, we used the established in vitro enteroid technique that uses media supplemented by the niche-derived morphogens, epidermal growth factor (E), Noggin (N) and R-spondin (S) (ENS medium) 21 . Normal-appearing crypts
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npg from Vil1-Grem1 mice readily formed branching enteroids not only in these standard conditions but also in the absence of Noggin supplementation (ES medium). Endogenous epithelial Grem1 expression could be overcome by addition of competing BMP ligands 2, 4 and 7 to medium without Noggin (ES + rBMP2,4,7), which inhibited Vil1-Grem1 enteroid development, indicating that the culture of non-dysplastic crypts was dependent on a source of BMP antagonist (Fig. 4a) . In contrast, culture of dysplastic mouse adenomas (Apc Min/− ) generated nonbranching clonogenic cystic spheroids, which could be successfully initiated and propagated in the absence of BMP antagonist or following addition of recombinant BMP ligands (Fig. 4a) . These data further support the notion that BMP antagonism is dispensable once Wnt-activating somatic mutations have occurred 12, 22 . Next, we separated and cultured villi from Vil1-Grem1 and age-matched wild-type littermates in order to assess whether aberrant epithelial Grem1 expression influenced the tumor-forming capacity of villus cells. In the presence of epidermal growth factor, Noggin, R-spondin and recombinant Wnt3a (W) (ENSW medium), clonogenic cystic spheroids did develop from Vil1-Grem1 mouse villi, but these were rare events (<0.1% of villi). We reasoned that the inefficiency of this transformation resulted from the short half-life of Wnt3a in the medium 23 . To counter this, we generated Vil1-Grem1; Apc Min/+ mice to activate the endogenous Wnt pathway. In extracted villi, germline Apc Min/+ mutation did induce an increase in villus Wnt target gene expression (Fig. 4b) . However, epithelial Grem1 reduced the expression of these Wnt targets in an Apc-mutant background while increasing the expression of the progenitor markers Sox9 and Ephb2 (Fig. 4b) . These results were consistent with our GSEA findings.
We then repeated villus culture taking care to sample from regions without microscopically visible polyps. Villi from wild-type and age-matched Apc Min/+ mice did not survive in culture. By contrast, villi from Vil1-Grem1; Apc Min/+ animals rapidly formed clonogenic spheroids that could be successfully propagated in long-term culture and were unaffected by the addition of competing BMP ligand to the media (Fig. 4a) . Somatic loss of heterozygosity of the wild-type Apc allele was seen in all spheroids, and this was coupled with a further increase in Wnt target gene expression (Fig. 4b-d) . npg Spheroids formed from mice as young as 23 d old, but transformation efficiency increased with the age of the mouse, and histological analysis showed that this coincided with the emergence of villus ECFs (Fig. 4e) . Taken together, these results suggest that modest Wnt activation induced by a single Apc mutation alone is insufficient for the clonogenic growth of villus spheroids in nondysplastic Apc Min/+ villi. However, epithelial Grem1-induced disruption of cell fate allows the persistence of progenitor cells on the villus, and if Wnt-activating somatic mutations are present within this accumulating, expanded progenitor population, these cells are capable of generating BMP antagonist-independent spheroid growth in the cell culture environment.
Grem1 and activated Wnt signaling act in a synergistic fashion Crossing Vil1-Grem1 mice with Apc Min/+ mice caused a profound exacerbation of intestinal tumorigenesis, with tumor burden in 2-month-old double-transgenic animals greater than that seen in animals with the individual parental mutations (Fig. 5a) . Vil1-Grem1; Apc Min/+ mice had to be killed at mean 57 d as opposed to >200 d for Apc Min/+ mice and >250 d for Vil1-Grem1 animals. Notably, morphological elements of the polyps from both parental strains could be seen in individual lesions in double-transgenic animals. In the colon, superficial aberrant crypt foci progressed to lesions with luminal surface, not crypt base dysplasia. In the small bowel, dysplasia arose from intravillus ectopic crypts contained within nondysplastic serrated epithelium ( Fig. 5b and Supplementary Fig. 5a ). Laser dissection of these different morphological elements demonstrated somatic loss of the wild-type Apc allele exclusively in the dysplastic crypts within the serrated villi (Fig. 5b) , indicating that somatic Apc inactivation provides a selective advantage and occurs rapidly in actively proliferating villus cells.
Grem1 knockout reduces Wnt-driven tumor progression Next, we induced widespread, multicompartmental Grem1 knockout in 6-week-old mice. To do this we used a tamoxifen-inducible, Cre-mediated recombination system driven by the chicken β-actin promoter and cytomegalovirus early enhancer, crossed with a homozygous Grem1-floxed mouse (Cagg-CreER T2 ; Grem1 fl/fl mice) 24 . We confirmed successful Grem1 knockout by qRT-PCR and in situ hybridization, but Cagg-CreER T2 ; Grem1 fl/fl animals had no consistent change in the expression of BMP constituents, Wnt targets or stem cell markers and developed no pathological phenotype, indicating possible functional redundancy or buffering of BMP antagonists in adult intestinal homeostasis (Supplementary Fig. 6 ). As we and others have seen epithelial and/or stromal upregulation of GREM1 in some, but not all, sporadic human intestinal polyps, cancers and cell lines [25] [26] [27] (Supplementary Figs. 5d and 7a) , we examined the effect of knockout of physiological Grem1 expression on Wnt-initiated tumor burden by crossing Cagg-CreER T2 ; Grem1 fl/fl mice with Apc Min mice. Grem1 knockout caused a significant reduction of Apc Min/+ mouse polyp burden (P interaction < 0.002 for all regions of the bowel, linear regression, Fig. 5c ) and size (P interaction < 0.001, linear regression, npg Supplementary Fig. 6d ), demonstrating that knockout of stromal and/or aberrant epithelial Grem1 expression ameliorates the development of conventional intestinal tumorigenesis. To investigate whether GREM1 might influence the behavior of human tumors, we analyzed associations between GREM1 expression and survival in two publically available CRC data sets. Individuals with above-median GREM1 expression had significantly shorter disease-free survival in both data sets (AMC-AJCCII-90 set, stage 2: log-rank P = 0.0162, MoffitVanderbilt-Royal Melbourne set, stages 1-3: log-rank P = 0.0112) ( Fig. 5d and Supplementary Fig. 5e) .
Collectively, these results strongly support the notion that GREM1 and Wnt signaling act in a synergistic fashion in the initiation and progression of intestinal polyps. We propose that in both human and mouse neoplasia resulting from aberrant GREM1 expression, there is a strong selective pressure for somatic Wnt activation in actively dividing ECFs, whereas in conventional Wnt-driven tumorigenesis, stromal-derived GREM1 provides a favorable microenvironment for the persistence of somatically mutant cells.
Epithelial GREM1 expression in sporadic traditional serrated adenomas On the basis of gene expression and somatic mutation profiles, a recent study divided sporadic colorectal cancer into three main molecularly distinct subtypes: CCS1, enriched for tumors with chromosomal instability; CCS2, enriched for tumors with microsatellite instability; and a third group, CCS3. This group was more heterogenous, appeared to arise from serrated adenoma precursors and gave rise to an aggressive subset of cancers with poor prognosis 28 . To see whether whole-tumor GREM1 expression correlated with this classification, we used The Cancer Genome Atlas RNA-seq data to match sporadic tumor samples to the published CCS1, CCS2 and CCS3 subtypes and found a highly significant correlation between high GREM1 expression and CCS3-subtype tumors (P < 0.0001, analysis of variance (ANOVA)) (Fig. 5d) .
Traditional serrated adenomas (TSAs) are distal colonic polyps with hitherto unknown pathogenesis that make up about 2% of the lesions removed at colonoscopy. The characteristic histological feature Figure 6 Model summarizing the proposed mechanistic consequences of disrupted GREM1 morphogen gradients. Aberrant ectopic epithelial expression of GREM1 disrupts the coupling of cell fate determination to position along the crypt-villus axis and allows persistence and expansion of an Lgr5-negative progenitor cell pool (characterized by aberrant SOX9 and EPHB2 expression) that forms orthogonal ectopic crypt foci. Aberrant cell proliferation in this progenitor cell population within these ECFs predisposes toward somatic (epi)mutation events and gives rise to neoplastic transformation (inset boxes). In vitro, the persistence of somatically mutated progenitor cells in dissected villi gives rise to clonogenic tumor spheroid growth from cells that have exited the crypt basal stem cell niche. Colored bars represent morphogen and gene expression gradients in the normal and pathological states. Blue squares represent physiological Grem1 expression from pericryptal myofibroblasts. CBC stem cells are colored red.
npg of these sporadic lesions is the development of ectopic crypt foci 29 . We collected and dissected individual crypts from four fresh TSA specimens. Individual crypt analysis of BMP antagonist expression revealed a mean 87-fold upregulation of epithelial GREM1 expression over surrounding normal mucosa (Fig. 5e) , which was significantly greater than that seen in conventional, hyperplastic and sessile serrated adenomas (P < 0.01, t-test, Supplementary Fig. 7a ). We validated epithelial GREM1 expression in a set of ten paraffin-embedded TSAs using mRNA in situ hybridization. We detected clearly visible epithelial GREM1 expression in a further six of ten polyps (Fig. 5f) . Immunohistochemical assessment, mutation and methylation analysis revealed a very similar molecular phenotype and somatic (epi)mutation pattern to HMPS polyps (Supplementary Fig. 7b,c) .
We observed CIMP in 33% of TSAs, and p16 INK4A promoter methylation correlated with p16 INK4A protein downregulation and resultant cell proliferation similar to the p16 INK4A and Ki-67 staining observed in Vil1-Grem1 mice (Supplementary Fig. 7d ). These data suggest that the ECFs that characterize sporadic TSAs also arise from disruption of homeostatic morphogen gradients and that in the majority of cases this is the consequence of aberrant epithelial GREM1 expression.
DISCUSSION
Here we use a mouse model of a human disease to demonstrate the pathogenetic mechanism in hereditary mixed polyposis syndrome (Fig. 6) . We hypothesize that aberrant epithelial GREM1 expression disrupts intestinal morphogen gradients, altering daughter cell fate and promoting the persistence of Lgr5-negative progenitor cells in ECFs distant from the crypt base. Cell proliferation within ECFs means that progenitor cells are prone to tumor-causing somatic mutations. Human HMPS polyps progress through KRAS or BRAF mutation and frequent selection of a very restricted set of APC mutations. In the mouse model, Grem1-initiated lesions advance through p16 loss and Ctnnb1 mutation, and once somatic mutation has occurred in some advanced lesions, epithelial Grem1 expression becomes redundant. Ex vivo culture of transgenic mouse villi demonstrates that persistence of somatically mutated villus cells can initiate clonogenic growth. Using mouse models, we have also shown the exacerbation or amelioration of conventional, Wnt-driven neoplasia initiation by Grem1 overexpression or knockout, respectively. Lastly, we show that epithelial expression of GREM1 also occurs in sporadic TSAs, lesions similarly characterized by the development of aberrantly proliferating cells in ectopic crypt foci, and that these lesions can thus be considered the sporadic equivalents of HMPS polyps. Multiple BMP antagonists have been described, with varying levels of intestinal expression and importance in intestinal homeostasis. There is much greater physiological expression of both GREM1 and GREM2 than of NOG in human intestinal stroma (Supplementary Fig. 5f ), and the importance of GREM1 has been highlighted by its causative role in HMPS 9 and the association of sporadic CRC with GREM1 common allelic variants 30 . The association of germline-inactivating NOG mutations with skeletal conditions such as symphalangism and tarsalcarpal coalition 31 correspondingly reflects the greater significance of NOG's role in bone development than in intestinal homeostasis. Previous investigation of the pathogenesis of juvenile polyposis led to the generation of mice expressing Xenopus nog under control of the Vil1 promoter 7 and mice expressing Xenopus nog under control of the Fabp1 promoter 8 . Both models initially developed intravillus ectopic crypts before progressing to a juvenile polyposis-like phenotype. The differences between small intestinal polyp morphology in these models and in the Vil1-Grem1 mouse may reflect the Xenopus origin of the nog, the relative importance of these different antagonists in intestinal homeostasis or fundamental differences in the ligand targets or biology of these BMP antagonists, which share minimal sequence homology. Human HMPS and JPS are pathogenically and morphologically distinct 32 , and the profound differences in pathogenesis, phenotype and somatic pathway progression between these conditions highlights how subtle alterations in the BMP signaling cascade can have different effects on intestinal tumorigenesis.
The histogenesis of colorectal neoplasia has historically been a subject of some debate: the classical bottom-up model favors dysplasia arising from the crypt basal stem cell niche 33 , whereas the top-down model proposes that dysplasia originates at the luminal surface and spreads downwards 34 . The identification of the Lgr5-positive CBC stem cell at the very base of the crypt 1 seemed to have settled the argument in favor of the bottom-up model. Here, we demonstrate that pathological disruption of morphogen gradients in animal models and human inherited and sporadic disease causes a profound change in the fate of cells situated outside of the crypt base stem and proliferative zone, with expansion of an Lgr5-negative progenitor cell population. These cells form ectopic crypt structures, proliferate, accumulate somatic mutations and are capable of initiating intestinal neoplasia, indicating that the crypt basal stem cell is not the exclusive cell of origin of all subtypes of colorectal cancer. Conceivable histogenic origins of this progenitor population include the vertical expansion of a crypt base progenitor population containing variably competent stem cells, the generation of an ectopic niche for a migrated Lgr5-negative stem cell and dedifferentiation of post-mitotic specialized intestinal epithelial cells. Very recently, Schwitalla et al. 35 have shown that activated nuclear factor-κB-induced mucosal inflammation in combination with constitutive epithelial Wnt signaling can also promote the initiation of neoplasia from cells situated outside the crypt base stem cell niche. Taken together, these studies highlight the importance of the intestinal microenvironment in maintaining stem cell homeostatic control and cell-fate determination. This work challenges the concept of a strict unidirectional tissue organizational hierarchy in the intestine and demonstrates that a top-down model of tumor histogenesis may fit some subtypes of inherited, sporadic and inflammation-associated colorectal cancers.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. Gene expression data have been deposited in the NCBI Gene Expression Omnibus with accession number GSE62307. 
ONLINE METHODS
Generation and genotyping of Vil1-Grem1 mice. Grem1 cDNA was amplified from normal mouse intestinal mesenchyme using the following primers F 5′-GACGTCGACCAATGGAGAGAC-3′ and R 5′-GAC GTCTGACGGACAAGCAA-3′, adding an AatII restriction enzyme site at each end. The excised cDNA fragment was then cloned into the Villin-MES-SV40polyA plasmid (kind gift from S. Robine) downstream of the 9-Kb Villin promoter (active after embryonic day E9). This plasmid was linearized with Kpn1 digestion. Transgenic mice were derived by pronuclear injection in BL6/129 mice using standard methods by the Transgenic Facility, WTCHG, Oxford University. To identify successful transmission, tail snips were taken from mice at weaning age and amplified by PCR using the following primers; F 5′-GAGGTCGAGGCTAAAGAAGA-3′ and R 5′-AC CTAGTGTCGGGCATCTCC-3′. Successful transmission was confirmed by Southern blot using standard methods. In brief, the probes were amplified using the following primers F 5′-AGGTAGGGAGGTCGAGGCTA-3′ and R 5′-CAACGCTCCCACAGTGTATG-3′. The probes were then radioactively labeled by random priming with α32P dCTP using the random primed labeling kit (Roche) as previously described 37 . 20 µg of genomic DNA was digested to completion with SphI and MscI restriction enzymes. The digested DNA was electrophoresed on 0.8% gels in 1× TBE overnight. After denaturation, the gels were blotted onto Hybond N+ membrane (GE Healthcare) overnight, UV crosslinked (Stratalinker, Stratagene) and hybridized with the radiolabeled probes. Hybridization and washing of Southern blots was performed using standard methods and detected a 2,079-bp region of the inserted transgene in founder mice (Supplementary Fig. 3c ). Three founder lines were established and all developed an identical phenotype. One line was arbitrarily chosen to be taken forward.
Mouse procedures. All procedures were carried out in accordance to Home Office UK regulations and the Animals (Scientific Procedures) Act 1986. All mice were housed at the animal unit at Functional Genomics Facility, Wellcome Trust Centre for Human Genetics, Oxford University. All strains used in this study were maintained on C57BL/6J background for ≥6 generations. To induce recombination in conditional lines, mice were treated with 1 mg tamoxifen by intraperitoneal injection for five days. Tissue preparation and histology. Both male and female mice were used throughout the study. Mice were killed at predefined time points (as indicated in the text) or when showing symptoms of intestinal polyps (anemia, hunching) by cervical dislocation. The intestinal tract was removed immediately and divided into small intestine (proximal/SB1, middle/SB2 and distal/SB3) and large intestine. The intestines were opened longitudinally using a gut preparation apparatus 40 , washed in PBS and fixed overnight in 10% neutral buffered formalin (NBF). For scoring of polyps, gut preparations were stained with 0.2% methylene blue for 10 s and washed in PBS for 20 min, and polyps were counted/measured using a dissecting microscope at ×3 magnification. Specimens of 10% formalinfixed tissue were embedded in paraffin and then sectioned at 4 µm. Fixed specimens were embedded and H&E stained following standard protocols.
Immunohistochemistry. Formalin-fixed, paraffin-embedded tissue sections (4 µm) were de-waxed in xylene and rehydrated through graded alcohols to water. Endogenous peroxidase was blocked using 1.6% H 2 O 2 for 20 min. Sections were then incubated in ABC (Vector labs) for 30 min. DAB solution was applied for 2-5 min and development of the color reaction was monitored microscopically. Slides were counterstained with hematoxylin, dehydrated, cleared and then mounted.
Alcian-blue stain for goblet cells. Sections were dewaxed in xylene for 5 min and then rehydrated through graded ethanols (100%, 90%, 70%) for 5 min each followed by 2 min in tap H 2 O. Slides were then stained in alcian-blue solution (Sigma) for 30 min, washed in running tap H 2 O for 2 min, and rinsed in dH 2 O. Slides were then stained in nuclear fast red solution (Sigma) for 5 min and washed in running tap H 2 O for 1 min. Slides were then dehydrated through degraded alcohols for 2-5 min each, before mounting a coverslip with DPX.
Immunohistochemical quantification. For mouse phenotype quantification analyses, we used no fewer than three animals per group (control and experimental, at age 10 months). To assess overall change in epithelial cell numbers between Vil1-Grem1 mice compared to age-matched, wild-type counterparts, we microscopically captured images of hemotoxylin-eosin-stained 4-µm sections of the small intestine and colon at ×10 magnification and then randomly selected crypts and villi, counting individual cells within these compartments. An average of 50 individual villi within the small intestine and 100 crypts were counted. Similarly, 100 crypts of the colon were counted, giving us enough power to run a t-test. Data are represented as total number of cells per crypt/villus. Excel was used to calculate means and standard error. To determine the proliferative index in experimental and control mice, a total of three mice per group were used. Small intestinal and colon sections were immunohistochemically labeled with Ki-67-specific antibody. Microscopic images at ×20 magnification were taken and number of Ki-67 positive cells per total epithelial cells in randomly selected 50 crypts (colon or small intestine) and 50 villi (small intestine) were counted. Data are represented as a percentage of Ki-67 + cells in each compartment. The percentage of goblets cells in epithelial cells of the villus (small intestine) and crypt (small intestine/colon) was quantified by counting Alcian blue-positive cells in at least 50 crypts of the colon/small intestine and 50 villi from small intestine in three mice of each genotype. Similarly, quantification of Paneth cells was determined by counting lysozyme-positive cells over total epithelial cells in three Vil1-Grem1 and three wild-type mice. To assess apoptosis, cleaved Caspase 3-positive cells over total number of epithelial cells per crypt (50 crypts in total) in small intestine/colon, and per villus (50 villi in total) in small intestine were counted. No randomization or blinding of mouse genotypes was used. All statistical analyses were done in Excel.
Individual crypt and villus isolation, RNA extraction and qRT-PCR. For both mouse and human individual crypt/villus isolation, biopsies were washed with PBS and incubated in 5 ml dissociation media (30 mM EDTA in DMEM without Ca 2+ and Mg 2+ , 0.5 mM DTT, 2% RNAlater (Life Technologies) for 10 min at room temperature. The digested tissue was then transferred to PBS and shaken vigorously for 30 s to release individual crypts and villi. Individual structures were selected using a drawn-out glass pipette under a dissection microscope and transferred to RLT buffer ready for subsequent RNA extraction with the RNeasy microkit (Qiagen) according to manufacturer's instructions. RNAs were treated with DNase I to degrade residual DNA. When required, complementary DNA was reverse transcribed in vitro using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). When using cDNA generated from individual crypts or villi, preamplification of these cDNAs was necessary before qRT-PCR. The TaqMan PreAmp (Applied Biosystems) kit was used following manufacturer's instructions. Absolute quantification qRT-PCR was performed on the ABI 7900HT cycler (Applied Biosystems) with GAPDPH/Gapdh serving as an endogenous control. A list of TaqMan Gene Expression assays (Applied Biosystems) used is available on request. The primary assumption in analyzing Real time PCR results is that the effect of a gene can be adjusted by subtracting Ct number of target gene from that of the reference gene (∆Ct). The ∆Ct for experimental and control can therefore be subject to t-test, which will yield the estimation of ∆∆Ct. In all cases the data met the normal distribution assumption of the t-test.
In situ hybridization. 4-µm sections were prepared using DEPC (Sigma)-treated H 2 O. In situ hybridization was carried out using the GREM1 (312831), PPIB npg
